Today, we have part one of our interview with Danny Kim, the Head of Corporate Development at WELT. WELT was founded in 2016 as a spin-off of Samsung to explore the intersection of healthcare and technology. WELT creates personalized digital therapeutics that combine sensor and digital biomarker technologies with therapeutic contents for the treatment of diseases with a high unmet medical need.
In the past, Danny served as the Director of Business Development at Soundable Health, VP at Contrary Capital, Corporate Development Analyst with Pear Therapeutics as an operator at PillPack (PillPack's biggest fanboy—Danny's unofficial title at the company); the company was acquired by Amazon for $1B during his stay.
This week's episode will be slightly different from our typical interview structure. Next week’s episode will be more traditional, where we deep dive into Danny’s background and his work at WELT.
What you will learn about today:
1.) How working directly under TJ Parker (CEO & Co-founder of Pill Pack, acq. By Amazon) fundamentally changed how Danny approaches problems and entrepreneurship.
2.) How do you balance the different needs of the multiple stakeholders (patients, health insurance, provider, pharmaceutical companies) in the therapeutics space?
3.) Why Amazon acquiring Pill Pack makes so much sense
If you enjoyed this episode, please subscribe for more and leave a rating on whichever platform you listen to your podcasts!
Sign up to receive updates on new episodes, exclusive Q&A, and future giveaways.
Check out our LinkedIn page where we share digital health news and new episodes!
Connect with Nico via Twitter for Tweets about digital health news and startups.